본문 바로가기
KERD
논문KCI 등재

Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis

2

조회

0

다운로드

11

인용

0

참고문헌

키워드

주제분류내과학

초록

Background/Aims: A high body mass index (BMI) is known to correlate with better survival in patients on hemodialysis (HD). However, the impacts of body composition and sarcopenia on survival have not been well studied in this population. Methods: One hundred and forty-two prevalent HD patients were recruited and followed prospectively for up to 4.5 years. Low muscle mass (measured using a portable, whole-body, bioimpedance spectroscopic device) was defined as a lean tissue index (LTI) two standard deviations (SD) or more below the normal gender-specific mean for young people. Low muscle strength was a handgrip strength (HGS) of less than 30 kg in males and less than 20 kg in females. Sarcopenia was considered present when both LTI and HGS were reduced. Results: The mean age was 59.8 ± 13.1 years; 57.0% were male and 47.2% had diabetes. Forty-seven patients (33.1%) had sarcopenia. During follow-up, 28 patients (19.7%) died, and low LTI (adjusted hazard ratio [HR], 2.77; 95% confidence interval [CI], 1.10 to 6.97) and low HGS (HR 5.65; 95% CI, 1.99 to 16.04) were independently associated with mortality. Sarcopenia was a significant predictor for death (HR, 6.99; 95% CI, 1.84 to 26.58; p = 0.004) and cardiovascular events (HR, 4.33; 95% CI, 1.51 to 12.43; p = 0.006). Conclusions: Sarcopenia was strongly associated with long-term mortality and cardiovascular events in HD patients. Assessment of muscle strength and muscle mass may provide additional prognostic information to survival in patients with end-stage renal disease.

Abstract

Background/Aims: A high body mass index (BMI) is known to correlate with better survival in patients on hemodialysis (HD). However, the impacts of body composition and sarcopenia on survival have not been well studied in this population. Methods: One hundred and forty-two prevalent HD patients were recruited and followed prospectively for up to 4.5 years. Low muscle mass (measured using a portable, whole-body, bioimpedance spectroscopic device) was defined as a lean tissue index (LTI) two standard deviations (SD) or more below the normal gender-specific mean for young people. Low muscle strength was a handgrip strength (HGS) of less than 30 kg in males and less than 20 kg in females. Sarcopenia was considered present when both LTI and HGS were reduced. Results: The mean age was 59.8 ± 13.1 years; 57.0% were male and 47.2% had diabetes. Forty-seven patients (33.1%) had sarcopenia. During follow-up, 28 patients (19.7%) died, and low LTI (adjusted hazard ratio [HR], 2.77; 95% confidence interval [CI], 1.10 to 6.97) and low HGS (HR 5.65; 95% CI, 1.99 to 16.04) were independently associated with mortality. Sarcopenia was a significant predictor for death (HR, 6.99; 95% CI, 1.84 to 26.58; p = 0.004) and cardiovascular events (HR, 4.33; 95% CI, 1.51 to 12.43; p = 0.006). Conclusions: Sarcopenia was strongly associated with long-term mortality and cardiovascular events in HD patients. Assessment of muscle strength and muscle mass may provide additional prognostic information to survival in patients with end-stage renal disease.

참고문헌 (35)

  1. Stenvinkel P, "Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure", Kidney Int, 55, pp.1899~1911 (1999)
  2. Metter EJ, "Age-associated loss of power and strength in the upper extremities in women and men", J Gerontol A Biol Sci Med Sci, 52, pp.B267~B276 (1997)
  3. Muscaritoli M, "Consensus definition of sarcopenia, cachexia and pre-cachexia : joint document elaborated by Special Interest Groups(SIG)"cachexia-anorexia in chronic wasting diseases"and"nutrition in geriatrics"", Clin Nutr, 29, pp.154~159 (2010)
  4. Kalantar-Zadeh K, "Survival advantages of obesity in dialysis patients", Am J Clin Nutr, 81, pp.543~554 (2005)
  5. Lowrie EG, "Body size, dialysis dose and death risk relationships among hemodialysis patients", Kidney Int, 62, pp.1891~1897 (2002)
  6. Leavey SF, "Body mass index and mortality in ‘healthier’as compared with ‘sicker’ haemodialysis patients : results from the Dialysis Outcomes and Practice Patterns Study(DOPPS)", Nephrol Dial Transplant, 16, pp.2386~2394 (2001)
  7. Wolfe RA, "Body size, dose of hemodialysis, and mortality", Am J Kidney Dis, 35, pp.80~88 (2000)
  8. Kopple JD, "Body weight-forheight relationships predict mortality in maintenance hemodialysis patients", Kidney Int, 56, pp.1136~1148 (1999)
  9. Sarkar SR, "Metabolic consequences of body size and body composition in hemodialysis patients", Kidney Int, 70, pp.1832~1839 (2006)
  10. Carrero JJ, "Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients", Clin Nutr, 27, pp.557~564 (2008)
  11. Heimburger O, "Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy", Am J Kidney Dis, 36, pp.1213~1225 (2000)
  12. Roshanravan B, "Association between physical performance and all-cause mortality in CKD", J Am Soc Nephrol, 24, pp.822~830 (2013)
  13. Kim JK, "Prevalence of and factors associated with sarcopenia in elderly patients with endstage renal disease", Clin Nutr, 33, pp.64~68 (2014)
  14. Isoyama N, "Comparative associations of muscle mass and muscle strength with mortality in dialysis patients", Clin J Am Soc Nephrol, 9, pp.1720~1728 (2014)
  15. Painter P, "The association of physical activity and physical function with clinical outcomes in adults with chronic kidney disease", Curr Opin Nephrol Hypertens, 22, pp.615~623 (2013)
  16. Steiber AL, "Subjective Global Assessment in chronic kidney disease : a review", J Ren Nutr, 14, pp.191~200 (2004)
  17. Carrero JJ, "Etiology of the protein-energy wasting syndrome in chronic kidney disease : a consensus statement from the International Society of Renal Nutrition and Metabolism(ISRNM)", J Ren Nutr, 23, pp.77~90 (2013)
  18. Fahal IH, "Physiological abnormalities of skeletal muscle in dialysis patients", Nephrol Dial Transplant, 12, pp.119~127 (1997)
  19. Fahal IH, "Uraemic sarcopenia : aetiology and implications", Nephrol Dial Transplant, 29, pp.1655~1665 (2014)
  20. Fouque D, "A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease", Kidney Int, 73, pp.391~398 (2008)
  21. Stenvinkel P, "Inflammation in end-stage renal disease : sources, consequences, and therapy", Semin Dial, 15, pp.329~337 (2002)
  22. Kalantar-Zadeh K, "Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients", Am J Kidney Dis, 38, pp.1343~1350 (2001)
  23. Zhang L, "Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy", J Am Soc Nephrol, 21, pp.419~427 (2010)
  24. Langen RC, "Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB", FASEB J, 15, pp.1169~1180 (2001)
  25. Mourkioti F, "NF-kappaB signaling in skeletal muscle : prospects for intervention in muscle diseases", J Mol Med(Berl), 86, pp.747~759 (2008)
  26. Delano MJ, "The origins of cachexia in acute and chronic inflammatory diseases", Nutr Clin Pract, 21, pp.68~81 (2006)
  27. Kraut JA, "Metabolic acidosis of CKD : diagnosis, clinical characteristics, and treatment", Am J Kidney Dis, 45, pp.978~993 (2005)
  28. Verove C, "Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure", J Ren Nutr, 12, pp.224~228 (2002)
  29. Caso G, "Control of muscle protein kinetics by acid-base balance", Curr Opin Clin Nutr Metab Care, 8, pp.73~76 (2005)
  30. Stein A, "Role of an improvement in acid-base status and nutrition in CAPD patients", Kidney Int, 52, pp.1089~1095 (1997)
  31. Visser M, "Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass(sarcopenia) : the Longitudinal Aging Study Amsterdam", J Clin Endocrinol Metab, 88, pp.5766~5772 (2003)
  32. Bischoff-Ferrari HA, "Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y", Am J Clin Nutr, 80, pp.752~758 (2004)
  33. Snijder MB, "Vitamin D status in relation to one-year risk of recurrent falling in older men and women", J Clin Endocrinol Metab, 91, pp.2980~2985 (2006)
  34. Pedersen BK, "Searching for the exercise factor: is IL-6 a candidate?", J Muscle Res Cell Motil, 24, pp.113~119 (2003)
  35. Pedersen BK, "Muscle-to-fat interaction: a two-way street?", J Physiol, 588(Pt 1), pp.21~ (2010)

관련 논문AI추천

이 간행물의 다른 논문 (28건)